STAT

AUGUST 3, 2023

New research that combines technology to sequence “ancient DNA” with direct-to-consumer genetic testing has identified tens of thousands people alive today who are genetically linked to enslaved and free African Americans who worked at a once-thriving Maryland iron forge in the late 18th and early 19th century. The findings, reported Thursday in Science , are a step toward restoring difficult-to-obtain ancestry knowledge to African Americans who descended from enslaved people, whos

246

246

PharmaVoice

AUGUST 3, 2023

A smaller player in the Alzheimer’s space, Prothena is approaching the next phase of treatments, including prevention and clinical trial evolution.

246

246

STAT

AUGUST 3, 2023

Patients are bracing for “D-Day,” the date their insurance companies will stop covering the drugs. Doctors are getting letters from insurance investigators discouraging new prescriptions. And pharmacies are being told by insurers to check for a specific diagnosis when filling prescriptions. It’s a charge on all fronts by insurance companies to contain the spiraling costs of a new class of weight loss-inducing drugs, the GLP-1s.

Diabetes 246

Diabetes 246

PharmaVoice

AUGUST 3, 2023

Pfizer’s recent earnings report could foretell major trouble in the market for pandemic products.

228

228

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

AUGUST 3, 2023

WASHINGTON — An already record-setting summer heat wave will continue through August and will put more than 51 million Americans at risk of health impacts, according to new data from federal health officials. Most of those vulnerable people live in 26 states and are expected to have at least five extreme heat days this month. Among the highest-risk counties, roughly 45% have high levels of uninsured adults and children and 18% have high senior populations, according to a relatively new mo

246

246

European Pharmaceutical Review

AUGUST 3, 2023

The Danish Medicines Agency (Lægemiddelstyrelsen) has announced the European Pharmacopoeia Commission has adopted a new European monograph, which describes quality requirements for the raw material Cannabis flower. EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

BioPharma Dive

AUGUST 3, 2023

One patient received its Duchenne gene therapy, Elevidys, this week and a handful more could follow shortly, surprising some analysts and raising near-term sales expectations.

98

98

STAT

AUGUST 3, 2023

Stressful experiences during childhood could have more far-reaching effects than previously thought, contributing to issues with daily tasks like getting dressed or preparing meals in older age, according to a new national analysis. The authors of the study , published Wednesday in the Journal of General Internal Medicine, say it is the first to link adverse childhood experiences (ACEs) with objective measures of functional impairment in older U.S. adults.

241

241

The Pharmacist

AUGUST 3, 2023

The total full-time equivalent (FTE) community pharmacy workforce has fallen by 6% in a year period, despite the overall number of pharmacists remaining ‘almost constant’, latest results from NHS England’s Community Workforce Survey 2022 has shown. Vacancy rates among pharmacists are up 16%, with indications that locum pharmacists are being used more and working fewer […] The post Total community pharmacy workforce drops 6% in a year appeared first on The Pharmacist.

Community Pharmacies 97

Community Pharmacies 97

STAT

AUGUST 3, 2023

A panel of advisers to the Centers for Disease Control and Prevention unanimously voted Thursday to recommend wide use among infants and some high-risk children of an antibody designed to protect against RSV , the country’s leading cause of infant hospitalization. The 10-0 recommendation from the Advisory Committee on Immunization Practices now goes to CDC Director Mandy Cohen, who is expected to accept it.

Immunity 238

Immunity Immunization Hospitals 238

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

AUGUST 3, 2023

Integrated care boards (ICBs) in northern England had the highest number of full-time-equivalent (FTE) community pharmacist vacancies last autumn, according to the results of a survey released today by NHS England. Greater Manchester ICB had the highest number of FTE community pharmacist vacancies (180), followed by North East and North Cumbria ICB at 154.

96

96

STAT

AUGUST 3, 2023

New treatments are delaying the progression of Alzheimer’s disease , giving people aging with memory decline the potential to live independently longer. But this benefit can only be fully realized if we ensure equitable access to care. Medicare’s policies are creating obstacles that make it more difficult for patients who are highly likely to benefit to obtain access to diagnosis and treatment.

223

223

Express Pharma

AUGUST 3, 2023

Granules India announced that Granules Pharmaceuticals located in Chantilly, Virginia, US has successfully completed the United States Food and Drug Administration (USFDA) Post-marketing Adverse Drug Experience (PADE) Inspection for all its entities in the US, including Granules India. The inspection was closed with zero observations. The inspection was conducted at Granules Pharmaceuticals from July 31, 2023 to August 03, 2023.

93

93

STAT

AUGUST 3, 2023

Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature paper , published in 2020, that suggested these microbes are consistently found in tumors, and that they create such specific signatures they could be used to identify cancer types with nearly 100% accuracy.

206

206

PharmExec

AUGUST 3, 2023

This podcast companion to our roundtable feature explores the transformative power of AI in pharmaceutical marketing, six months after the arrival of ChatGPT.

98

98

STAT

AUGUST 3, 2023

Several Latino advocacy groups and more than 100 clinicians from dozens of countries are lending their voices to an expanding campaign to pressure Vertex Pharmaceuticals to widen access to its cystic fibrosis medications. In separate letters sent to the company in recent weeks, the health care providers and advocates maintained there is a notable disparity in access to Vertex medicines between mostly wealthy nations and low- and middle-income countries.

Drug Pricing 202

Drug Pricing 202

PharmaTech

AUGUST 3, 2023

Waters XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.

97

97

STAT

AUGUST 3, 2023

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

197

197

BioPharma Dive

AUGUST 3, 2023

The company disclosed the study result alongside second quarter earnings showing Lumakras sales were flat versus the same period one year prior.

98

98

STAT

AUGUST 3, 2023

WASHINGTON — A new White House task force on drug shortages held a rare in-person meeting last Friday with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm policies for stemming shortages of cancer drugs.

Hospitals 196

Hospitals 196

BioPharma Dive

AUGUST 3, 2023

Sales of the company’s COVID-19 vaccine plummeted 94% year over year. But executives believe newer products can help revenue rebound.

Vaccines 98

Vaccines 98

STAT

AUGUST 3, 2023

Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the Pharmalot campus, where things have settled down now that the short person has left for an institution of higher learning and the official mascots have assumed their formal snoozing positions. As for us, we are dutifully concocting a few needed cups of stimulation as we dig in for another busy day.

Labelling 189

Labelling Diabetes 189

Pharmaceutical Technology

AUGUST 3, 2023

The impact of artificial intelligence has been profoundly felt in the drug discovery space, with increased interest in AI in recent years.

98

98

STAT

AUGUST 3, 2023

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September. Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts.

188

188

Express Pharma

AUGUST 3, 2023

Pharma companies with an annual turnover of over Rs 250 crore will have to mandatorily adopt Good Manufacturing Practices (GMP) within six months, said Mansukh Mandaviya, Union Health Minister said on Wednesday. The minister informed that companies with a turnover of less than Rs 250 crore will have to adopt GMP within 12-months. The companies failing to follow the timelines may be penalised, he added.

82

82

STAT

AUGUST 3, 2023

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss how some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

181

181

Pharma Times

AUGUST 3, 2023

The candidate is a stroma-degrading oncolytic adenovirus for the treatment of pancreatic cancer - News - PharmaTimes

97

97

STAT

AUGUST 3, 2023

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated. That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT.

173

173

Outsourcing Pharma

AUGUST 3, 2023

At-risk families of patients diagnosed with motor neurone disease (MND), better known in the US as amyotrophic lateral sclerosis (ALS) will now have access to genetic sequencing thanks to a financial award from Innovate UK.

98

98

Pharma Times

AUGUST 3, 2023

MHRA has made the company a member of the UK GLP compliance monitoring programme - News - PharmaTimes

98

98

World Pharma News

AUGUST 3, 2023

Research published in Science today shows that a naturally occurring bacterium discovered by GSK scientists - Delftia tsuruhatensis Tres Cantos 1 (TC1) - could be the basis for new anti-malarial interventions. Studies done in collaboration at the Johns Hopkins Malaria Research Institute at Johns Hopkins Bloomberg School of Public Health show that the bacterium can significantly reduce the malaria parasite load in both the mosquito midgut and salivary glands indicating the potential of TC1 to inh

77

77

Pharmaceutical Technology

AUGUST 3, 2023

AAHI is developing a novel RNA vaccine that overcomes manufacturing and storage limitations to increase accessibility.

Vaccines 97

Vaccines 97

Pharmaceutical Commerce

AUGUST 3, 2023

The agreement provides Scripta patients with another option when purchasing medication.

Drug Pricing 88

Drug Pricing 88

Pharmaceutical Technology

AUGUST 3, 2023

ABM Therapeutics has received ODD from the US FDA for ABM-1310 to treat patients with glioblastoma (GBM) harbouring the BRAF V600 mutation.

80

80

pharmaphorum

AUGUST 3, 2023

PacBio builds in short-read sequencing with $110m Apton buy Phil.

97

97